These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 16635520)
1. Accurate prediction of need for invasive treatment in alpha1-blocker treated patients with benign prostatic hyperplasia not possible: bootstrap validation analysis. Kiemeney LA; Mochtar CA; Straatman H Urology; 2006 May; 67(5):984-9. PubMed ID: 16635520 [TBL] [Abstract][Full Text] [Related]
2. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting. Mochtar CA; Kiemeney LA; Laguna MP; van Riemsdijk MM; Barnett GS; Debruyne FM; de la Rosette JJ Urology; 2005 Feb; 65(2):300-5. PubMed ID: 15708042 [TBL] [Abstract][Full Text] [Related]
3. Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. Mochtar CA; Kiemeney LA; van Riemsdijk MM; Laguna MP; Debruyne FM; de la Rosette JJ J Urol; 2006 Jan; 175(1):213-6. PubMed ID: 16406914 [TBL] [Abstract][Full Text] [Related]
4. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms. Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690 [TBL] [Abstract][Full Text] [Related]
5. PSA velocity in conservatively managed BPH: can it predict the need for BPH-related invasive therapy? Mochtar CA; Kiemeney LA; Laguna MP; Debruyne FM; de la Rosette JJ Prostate; 2006 Sep; 66(13):1407-12. PubMed ID: 16741919 [TBL] [Abstract][Full Text] [Related]
6. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100 [TBL] [Abstract][Full Text] [Related]
7. Contemporary patients with LUTS/BPH requiring prostatectomy have long-term history of treatment with alpha1-blockers and large prostates compared with past cases. Takeuchi M; Masumori N; Tsukamoto T Urology; 2009 Sep; 74(3):606-9. PubMed ID: 19586655 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352 [TBL] [Abstract][Full Text] [Related]
9. [The risk of fracture with taking alpha blockers for treating benign prostatic hyperplasia]. Lee J; Choi NK; Jung SY; Kim YJ; Seong JM; Oh SJ; Park BJ J Prev Med Public Health; 2009 May; 42(3):165-70. PubMed ID: 19491559 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of medical treatment in benign prostatic hyperplasia. Kim CI; Chang HS; Kim BK; Park CH Urology; 2006 Nov; 68(5):1015-9. PubMed ID: 17095071 [TBL] [Abstract][Full Text] [Related]
11. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [TBL] [Abstract][Full Text] [Related]
12. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. Roehrborn CG BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681 [TBL] [Abstract][Full Text] [Related]
13. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate. Naslund MJ; Miner M Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044 [TBL] [Abstract][Full Text] [Related]
14. A novel approach to the treatment of benign prostatic hyperplasia. Horváth K; Walter G; Varga A; Romics I BJU Int; 2006 Jun; 97(6):1252-5. PubMed ID: 16686721 [TBL] [Abstract][Full Text] [Related]
15. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia. Nichol MB; Knight TK; Wu J; Barron R; Penson DF J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986 [TBL] [Abstract][Full Text] [Related]
16. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359 [TBL] [Abstract][Full Text] [Related]
17. Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia. Kojima Y; Sasaki S; Kubota Y; Hayase M; Hayashi Y; Shinoura H; Tsujimoto G; Kohri K J Urol; 2008 Mar; 179(3):1040-6. PubMed ID: 18206918 [TBL] [Abstract][Full Text] [Related]
18. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension]. Yang MG; Zhao XK Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564 [TBL] [Abstract][Full Text] [Related]
19. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery. Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia. Nickel JC; Sander S; Moon TD Int J Clin Pract; 2008 Oct; 62(10):1547-59. PubMed ID: 18822025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]